CN106893784A - 用于预测肝癌预后的lncRNA标志物 - Google Patents
用于预测肝癌预后的lncRNA标志物 Download PDFInfo
- Publication number
- CN106893784A CN106893784A CN201710303403.7A CN201710303403A CN106893784A CN 106893784 A CN106893784 A CN 106893784A CN 201710303403 A CN201710303403 A CN 201710303403A CN 106893784 A CN106893784 A CN 106893784A
- Authority
- CN
- China
- Prior art keywords
- expression
- lncrna
- prognosis
- patient
- lrrc3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Databases & Information Systems (AREA)
- Evolutionary Computation (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Computational Biology (AREA)
- Oncology (AREA)
- Software Systems (AREA)
- Public Health (AREA)
- Evolutionary Biology (AREA)
- Epidemiology (AREA)
- Data Mining & Analysis (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Bioethics (AREA)
- Artificial Intelligence (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710303403.7A CN106893784A (zh) | 2017-05-02 | 2017-05-02 | 用于预测肝癌预后的lncRNA标志物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710303403.7A CN106893784A (zh) | 2017-05-02 | 2017-05-02 | 用于预测肝癌预后的lncRNA标志物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106893784A true CN106893784A (zh) | 2017-06-27 |
Family
ID=59197218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710303403.7A Withdrawn CN106893784A (zh) | 2017-05-02 | 2017-05-02 | 用于预测肝癌预后的lncRNA标志物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106893784A (zh) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107858434A (zh) * | 2017-12-22 | 2018-03-30 | 复旦大学附属肿瘤医院 | lncRNA在肝癌诊断以及预后预测中的应用 |
CN108611419A (zh) * | 2018-05-11 | 2018-10-02 | 福建医科大学孟超肝胆医院 | 一种用于肝癌患者预后风险评估的基因检测试剂盒及应用 |
CN108728534A (zh) * | 2018-05-23 | 2018-11-02 | 王辉云 | 4-LncRNA分子标签用于肝癌预后评估的试剂盒 |
CN110577998A (zh) * | 2019-01-31 | 2019-12-17 | 上海交通大学医学院附属仁济医院 | 预测肝癌术后早期复发风险分子模型的构建及其应用评估 |
CN110964800A (zh) * | 2019-09-20 | 2020-04-07 | 北京航空航天大学 | 用于预测早产风险的cfRNA标志物 |
CN111088352A (zh) * | 2019-11-28 | 2020-05-01 | 浙江大学 | 一种多基因肝癌预后分级体系的建立方法及应用 |
CN111118143A (zh) * | 2020-01-16 | 2020-05-08 | 西安市红会医院 | 检测及靶向rp11-754b17.1的试剂及其在关节炎中的应用 |
CN111235263A (zh) * | 2020-01-16 | 2020-06-05 | 西安市红会医院 | 诊治骨关节炎的靶基因 |
CN111304326A (zh) * | 2020-02-22 | 2020-06-19 | 四川省人民医院 | 检测及靶向lncRNA生物标志物的试剂及其在肝细胞癌中的应用 |
WO2020181752A1 (zh) * | 2019-03-11 | 2020-09-17 | 中国医学科学院肿瘤医院 | 肝细胞癌早筛试剂盒及其制备方法和用途 |
CN112382341A (zh) * | 2020-11-18 | 2021-02-19 | 河南科技大学第一附属医院 | 一种用于鉴定食管鳞癌预后相关的生物标志物的方法 |
CN113201590A (zh) * | 2020-08-05 | 2021-08-03 | 上海健康医学院 | 用于评估肝细胞癌早期复发风险的lncRNA、评估方法及装置 |
CN113234833A (zh) * | 2021-07-09 | 2021-08-10 | 北京泱深生物信息技术有限公司 | 一种胰腺癌的预后标志物、预后风险评估模型及其应用 |
CN113517023A (zh) * | 2021-05-18 | 2021-10-19 | 柳州市人民医院 | 与性别相关的肝癌预后标志性因素及其筛选方法 |
CN113564261A (zh) * | 2021-09-26 | 2021-10-29 | 广州医科大学附属肿瘤医院 | 与肝细胞癌相关的lncRNA及其应用 |
CN113801938A (zh) * | 2021-10-28 | 2021-12-17 | 安徽同科生物科技有限公司 | 一种生物标志物组合及其在预测子宫内膜癌患者预后方面的应用 |
CN113832227A (zh) * | 2021-09-17 | 2021-12-24 | 中山大学孙逸仙纪念医院 | 一种肝细胞肝癌患者预后预测模型的构建及应用 |
CN113957145A (zh) * | 2021-10-19 | 2022-01-21 | 中国医学科学院肿瘤医院 | m6A相关lncRNA在预测小细胞肺癌预后和化疗反应的应用 |
CN116162708A (zh) * | 2022-12-29 | 2023-05-26 | 上海志药科技有限公司 | lncRNA LOC105376270在制备诊断原发性肝癌的试剂盒中的应用 |
-
2017
- 2017-05-02 CN CN201710303403.7A patent/CN106893784A/zh not_active Withdrawn
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107858434A (zh) * | 2017-12-22 | 2018-03-30 | 复旦大学附属肿瘤医院 | lncRNA在肝癌诊断以及预后预测中的应用 |
CN107858434B (zh) * | 2017-12-22 | 2020-10-09 | 复旦大学附属肿瘤医院 | lncRNA在肝癌诊断以及预后预测中的应用 |
CN108611419A (zh) * | 2018-05-11 | 2018-10-02 | 福建医科大学孟超肝胆医院 | 一种用于肝癌患者预后风险评估的基因检测试剂盒及应用 |
CN108728534A (zh) * | 2018-05-23 | 2018-11-02 | 王辉云 | 4-LncRNA分子标签用于肝癌预后评估的试剂盒 |
CN110577998A (zh) * | 2019-01-31 | 2019-12-17 | 上海交通大学医学院附属仁济医院 | 预测肝癌术后早期复发风险分子模型的构建及其应用评估 |
WO2020181752A1 (zh) * | 2019-03-11 | 2020-09-17 | 中国医学科学院肿瘤医院 | 肝细胞癌早筛试剂盒及其制备方法和用途 |
CN110964800A (zh) * | 2019-09-20 | 2020-04-07 | 北京航空航天大学 | 用于预测早产风险的cfRNA标志物 |
CN110964800B (zh) * | 2019-09-20 | 2021-10-22 | 北京航空航天大学 | 用于预测早产风险的cfRNA标志物 |
CN111088352A (zh) * | 2019-11-28 | 2020-05-01 | 浙江大学 | 一种多基因肝癌预后分级体系的建立方法及应用 |
CN111088352B (zh) * | 2019-11-28 | 2022-02-08 | 浙江大学 | 一种多基因肝癌预后分级体系的建立方法及应用 |
CN111118143A (zh) * | 2020-01-16 | 2020-05-08 | 西安市红会医院 | 检测及靶向rp11-754b17.1的试剂及其在关节炎中的应用 |
CN111118143B (zh) * | 2020-01-16 | 2020-09-15 | 西安市红会医院 | 检测及靶向rp11-754b17.1的试剂及其在关节炎中的应用 |
CN111235263B (zh) * | 2020-01-16 | 2020-09-01 | 西安市红会医院 | 诊治骨关节炎的靶基因 |
CN111235263A (zh) * | 2020-01-16 | 2020-06-05 | 西安市红会医院 | 诊治骨关节炎的靶基因 |
CN111304326A (zh) * | 2020-02-22 | 2020-06-19 | 四川省人民医院 | 检测及靶向lncRNA生物标志物的试剂及其在肝细胞癌中的应用 |
CN113201590A (zh) * | 2020-08-05 | 2021-08-03 | 上海健康医学院 | 用于评估肝细胞癌早期复发风险的lncRNA、评估方法及装置 |
CN113201590B (zh) * | 2020-08-05 | 2024-05-07 | 上海健康医学院 | 用于评估肝细胞癌早期复发风险的lncRNA、评估方法及装置 |
CN112382341B (zh) * | 2020-11-18 | 2023-05-26 | 河南科技大学第一附属医院 | 一种用于鉴定食管鳞癌预后相关的生物标志物的方法 |
CN112382341A (zh) * | 2020-11-18 | 2021-02-19 | 河南科技大学第一附属医院 | 一种用于鉴定食管鳞癌预后相关的生物标志物的方法 |
CN113517023A (zh) * | 2021-05-18 | 2021-10-19 | 柳州市人民医院 | 与性别相关的肝癌预后标志性因素及其筛选方法 |
CN113517023B (zh) * | 2021-05-18 | 2023-04-25 | 柳州市人民医院 | 与性别相关的肝癌预后标志性因素及筛选方法 |
CN113234833A (zh) * | 2021-07-09 | 2021-08-10 | 北京泱深生物信息技术有限公司 | 一种胰腺癌的预后标志物、预后风险评估模型及其应用 |
CN113832227B (zh) * | 2021-09-17 | 2022-07-05 | 中山大学孙逸仙纪念医院 | 一种肝细胞肝癌患者预后预测模型的构建及应用 |
CN113832227A (zh) * | 2021-09-17 | 2021-12-24 | 中山大学孙逸仙纪念医院 | 一种肝细胞肝癌患者预后预测模型的构建及应用 |
CN113564261B (zh) * | 2021-09-26 | 2021-12-07 | 广州医科大学附属肿瘤医院 | 与肝细胞癌相关的lncRNA及其应用 |
CN113564261A (zh) * | 2021-09-26 | 2021-10-29 | 广州医科大学附属肿瘤医院 | 与肝细胞癌相关的lncRNA及其应用 |
CN113957145A (zh) * | 2021-10-19 | 2022-01-21 | 中国医学科学院肿瘤医院 | m6A相关lncRNA在预测小细胞肺癌预后和化疗反应的应用 |
CN113957145B (zh) * | 2021-10-19 | 2023-09-26 | 中国医学科学院肿瘤医院 | m6A相关lncRNA在预测小细胞肺癌预后和化疗反应的应用 |
CN113801938A (zh) * | 2021-10-28 | 2021-12-17 | 安徽同科生物科技有限公司 | 一种生物标志物组合及其在预测子宫内膜癌患者预后方面的应用 |
CN116162708A (zh) * | 2022-12-29 | 2023-05-26 | 上海志药科技有限公司 | lncRNA LOC105376270在制备诊断原发性肝癌的试剂盒中的应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106893784A (zh) | 用于预测肝癌预后的lncRNA标志物 | |
JP6246845B2 (ja) | 遺伝子発現を用いた前立腺癌の予後を定量化する方法 | |
ES2754434T3 (es) | Métodos de pronóstico de cáncer de próstata | |
US20080206756A1 (en) | Biomarker panel for colorectal cancer | |
TWI680296B (zh) | 用於檢測胰腺癌的基因標誌物、試劑組及胰腺癌檢測方法 | |
JP2019527544A (ja) | 分子マーカー、参照遺伝子、及びその応用、検出キット、並びに検出モデルの構築方法 | |
ES2527062T3 (es) | Supervivencia y recurrencia del cáncer de próstata | |
CN107858434A (zh) | lncRNA在肝癌诊断以及预后预测中的应用 | |
CN110229899B (zh) | 用于结直肠癌早期诊断或预后预测的血浆标记物组合 | |
TW201905207A (zh) | 用於檢測肝癌的基因標誌物及其用途 | |
CN106755343A (zh) | 胰腺癌预后诊断分子标记物 | |
CN111518908B (zh) | 尿液前列腺癌标志物组合及其在制备精准诊断试剂中的用途 | |
US20180051342A1 (en) | Prostate cancer survival and recurrence | |
Alexandrescu et al. | Melanoma-specific marker expression in skin biopsy tissues as a tool to facilitate melanoma diagnosis | |
JP2015107091A (ja) | 膵臓がんの検出キット及び検出方法 | |
CN110331207A (zh) | 肺腺癌生物标志物及相关应用 | |
US20150329911A1 (en) | Nucleic acid biomarkers for prostate cancer | |
AU2018428853A1 (en) | Methods and compositions for the analysis of cancer biomarkers | |
CN106367509A (zh) | Loc100128675作为检测前列腺癌的分子标记物及其在诊断试剂盒中的应用 | |
CN106498062A (zh) | 一种诊断前列腺癌的产品及其应用 | |
CN106367526A (zh) | 一种诊断前列腺癌的产品及其应用 | |
CN106282366A (zh) | 一种与前列腺癌相关的分子标记物及其应用 | |
CN110273000A (zh) | 检测锌指蛋白468表达水平的试剂的应用和试剂盒 | |
CN110295232A (zh) | 用于结直肠癌的microRNA生物标记物 | |
JP6103866B2 (ja) | 大腸ガン検出方法、診断用キット及びdnaチップ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Room 1210, Building 3, Ronghua Xintai Building, 10 Ronghua South Road, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing Applicant after: BEIJING MEDINTELL BIOMED Co.,Ltd. Address before: 100080 Beijing city Haidian District Shanyuan Street No. 1 cubic court building room 3103 Applicant before: BEIJING MEDINTELL BIOMED Co.,Ltd. |
|
CB02 | Change of applicant information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200228 Address after: Room 2503, Qianshan building, building D2, Qingdao International Innovation Park Phase II, No. 1, Keyuan Weiyi Road, Laoshan District, Qingdao, Shandong Province Applicant after: Qingdao Yangshen biomedical Co.,Ltd. Address before: Room 1210, Building 3, Ronghua Xintai Building, 10 Ronghua South Road, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing Applicant before: BEIJING MEDINTELL BIOMED Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170627 |
|
WW01 | Invention patent application withdrawn after publication |